96 related articles for article (PubMed ID: 2472052)
1. [Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)].
Nukui M; Nakao M; Nakagawa S; Toyoda K; Takada H; Ebisui K; Watanabe H; Miyakoda K; Kobayashi T; Fujiwara M
Hinyokika Kiyo; 1989 Mar; 35(3):415-20. PubMed ID: 2472052
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with reactivated prostatic cancer].
Kazama T; Katayama T; Umeda K; Akiya T; Nakada T
Hinyokika Kiyo; 1986 Feb; 32(2):201-5. PubMed ID: 2425607
[TBL] [Abstract][Full Text] [Related]
3. [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
Yoshimoto J; Ochi J; Tanahashi T; Nanba K; Saegusa M; Hara M; Akagi T; Obama T; Tsushima T; Ozaki Y
Gan To Kagaku Ryoho; 1987 Feb; 14(2):434-9. PubMed ID: 2434029
[TBL] [Abstract][Full Text] [Related]
4. [Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
Ushiyama T; Ihara H; Kurita Y; Kageyama S; Ueda D; Mugiya S; Yamaguchi Y; Nakano M; Suzuki K; Kawabe K
Hinyokika Kiyo; 1993 Dec; 39(12):1139-44. PubMed ID: 8285162
[TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy with ifosfamide (or cyclophosphamide), adriamycin, cis-platinum and peplomycin (IAPP) for hormonally resistant metastatic prostatic cancer].
Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
Hinyokika Kiyo; 1991 Dec; 37(12):1657-62. PubMed ID: 1723841
[TBL] [Abstract][Full Text] [Related]
6. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with advanced stage D adenocarcinoma of the prostate].
Yoshimoto J; Nasu Y; Akagi T; Obama T; Tsushima T; Ozaki Y; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1985 Jan; 76(1):1-9. PubMed ID: 2409318
[No Abstract] [Full Text] [Related]
8. [Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer].
Hirabayashi K; Okada E; Nakazuma Y; Akamatsu Y; Sezaki H; Ohta M; Nakanishi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):341-8. PubMed ID: 1376759
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer].
Takeuchi S; Fukui I; Higashi Y; Andoh M; Kihara K; Kitahara S; Horiuchi S; Oshima H
Hinyokika Kiyo; 1989 Sep; 35(9):1513-7. PubMed ID: 2816618
[TBL] [Abstract][Full Text] [Related]
10. [Chemo-endocrine therapy for newly diagnosed stage D2 prostate cancer].
Saito T; Kitamura Y; Komatsubara S
Hinyokika Kiyo; 2005 Dec; 51(12):789-92. PubMed ID: 16440724
[TBL] [Abstract][Full Text] [Related]
11. [Continuous subcutaneous infusion of peplomycin for advanced prostatic cancer patients].
Satake I; Tari K
Hinyokika Kiyo; 1985 May; 31(5):875-83. PubMed ID: 2413747
[TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
13. [Response to chemotherapy in endocrine therapy-relapsed and -resistant prostate cancer].
Akimoto S; Akakura K; Masai M; Shimazaki J
Hinyokika Kiyo; 1991 Jan; 37(1):31-7. PubMed ID: 1707216
[TBL] [Abstract][Full Text] [Related]
14. [Reactivation of prostatic cancer and chemotherapy in reactivated prostatic cancer].
Fuse H; Ando K; Hara S; Zama S; Shimazaki J
Hinyokika Kiyo; 1985 Feb; 31(2):281-7. PubMed ID: 2409787
[TBL] [Abstract][Full Text] [Related]
15. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
[TBL] [Abstract][Full Text] [Related]
16. [Beneficial effect of cisplatin based combination chemotherapy on adenocarcinoma of the lung].
Ueoka H; Ohnoshi T; Numata T; Kawahara S; Nishii K; Yonei T; Yamashita H; Ishii J; Moritaka T; Kiura K
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3559-65. PubMed ID: 2479339
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of prostatic cancer by intramuscular administration and intratumor injection of peplomycin].
Fujimoto Y; Okano M; Takeuchi T; Saito A; Fujihiro S; Kuriyama M; Sakai S; Nishiura T
Hinyokika Kiyo; 1983 Nov; 29(11):1433-41. PubMed ID: 6203378
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma.
Daliani DD; Assikis V; Tu SM; Papandreou CN; Pagliaro LC; Holtkamp T; Wang X; Thall PF; Logothetis CJ
Cancer; 2003 Feb; 97(3):561-7. PubMed ID: 12548597
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for endocrine-therapy-refractory prostate cancer.
Akimoto S; Ohki T; Akakura K; Masai M; Shimazaki J
Cancer Chemother Pharmacol; 1994; 35 Suppl():S18-22. PubMed ID: 7527733
[TBL] [Abstract][Full Text] [Related]
20. [Ifosfamide in combined hormonochemotherapy on prostate cancer].
Fujita K; Matsushima H; Nakano M; Kaneko T
Gan To Kagaku Ryoho; 1994 Feb; 21(2):227-30. PubMed ID: 8311493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
